Overview
- Description
The company develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.
- Website
- Country
- Finland
- Sector
- Health Biotechnology
The company develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.
The company develops cancer immunotherapies using engineered oncolytic adenoviruses to enhance T-cell responses.